Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1958 2
1959 6
1960 4
1961 3
1962 1
1963 2
1964 2
1965 4
1966 1
1967 1
1968 1
1969 4
1970 1
1971 3
1972 6
1973 4
1974 4
1975 6
1976 6
1977 4
1978 3
1979 1
1980 1
1981 2
1982 1
1983 1
1984 5
1985 7
1986 8
1987 3
1988 9
1989 5
1990 4
1991 4
1993 1
1994 3
1995 2
1996 1
1997 1
1998 2
1999 4
2017 1
2018 2
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Insulin antibodies.
PAV J, JEZKOVA Z, SKRHA F. PAV J, et al. Lancet. 1963 Aug 3;2(7301):221-2. doi: 10.1016/s0140-6736(63)90117-x. Lancet. 1963. PMID: 13942063 No abstract available.
The effectiveness of quality control samples in pharmaceutical bioanalysis.
Keller S, Quiroz J, Christopher D, Wickremsinhe E, Geng W, Hawthorne G, James C, Katterle Y, Li W, Liu G, Mayer A, Paton M, Pav J, Potter J, Vergis J, Wang J, Westcott-Baker L, Woolf E, Xue Y. Keller S, et al. Among authors: pav j. Bioanalysis. 2021 Feb;13(3):135-145. doi: 10.4155/bio-2020-0265. Epub 2021 Feb 4. Bioanalysis. 2021. PMID: 33538614
Isoamylases in diabetes mellitus.
Skrha J, Stĕpán J, Havránek T, Skrha F, Herfort K, Sramkova J, Pav J. Skrha J, et al. Among authors: pav j. Diabetologia. 1981 Feb;20(2):129-33. doi: 10.1007/BF00262015. Diabetologia. 1981. PMID: 6162699 No abstract available.
[Thoughts on insulin therapy].
Páv J. Páv J. Cas Lek Cesk. 1994 Jun 27;133(13):394-6. Cas Lek Cesk. 1994. PMID: 8062330 Review. Czech.
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
Zhou J, Limsakun T, Yin O, Warren V, Zamora C, Atiee G, Kochan J, Pav J, Kobayashi F, Vashi V, Dishy V. Zhou J, et al. Among authors: pav j. J Clin Pharmacol. 2019 Dec;59(12):1669-1677. doi: 10.1002/jcph.1474. Epub 2019 Jun 27. J Clin Pharmacol. 2019. PMID: 31243790 Clinical Trial.
A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor.
Dennie J, Vandell AG, Inoue S, Gajee R, Pav J, Zhang G, Zamora C, Masuda N, Uchiyama M, Yamada M, Senaldi G. Dennie J, et al. Among authors: pav j. J Clin Pharmacol. 2018 Dec;58(12):1557-1565. doi: 10.1002/jcph.1151. Epub 2018 May 10. J Clin Pharmacol. 2018. PMID: 29746725 Clinical Trial.
[FAT--SOURCE OF ENERGY FOR THE BODY].
PAV J. PAV J. Cas Lek Cesk. 1963 Nov 8;102:1233-8. Cas Lek Cesk. 1963. PMID: 14113490 Review. Czech. No abstract available.
Risk calculation of type 2 diabetes.
Haas T, Svacina S, Pav J, Hovorka R, Sucharda P, Sonka J. Haas T, et al. Among authors: pav j. Comput Methods Programs Biomed. 1994 Jan;41(3-4):297-303. doi: 10.1016/0169-2607(94)90061-2. Comput Methods Programs Biomed. 1994. PMID: 8187472
141 results